Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06754917 · ClinicalTrials.gov registry record · NA
Feasibility Testing of the "Face-Forward-Web" Program for Chronic Orofacial Pain
A NA study of Facial Pain and Orofacial Pain, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06754917: Recruiting NA study of Facial Pain and Orofacial Pain, sponsored by Massachusetts General Hospital.
NCT06754917 is a NA study of Facial Pain and Orofacial Pain that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 30 participants, below the 57-participant average among 3 other Facial Pain trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06754917, a NA study of Facial Pain and Orofacial Pain, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to conduct a feasibility open pilot study (N=Up to 20) with exit interviews to assess the feasibility, acceptability, and credibility of the study protocol and Face-Forward-Web; a web-based mind-body intervention for adult patients with COP. Deliverables: \[1\] Adapt and refine open pilot protocol, patient recruitment, and other study materials. \[2\] Assess the feasibility, acceptability, and credibility of Face-Forward-Web and optimize the intervention methodology in preparation for a future efficacy study. This research leverages mixed methods information to evaluate the feasibility, acceptability, and credibility of Face-Forward-Web and optimize the intervention and study methodology in preparation for the subsequent pilot study and again later, for a pilot feasibility randomized control trial (RCT).
Primary Outcome
Assessed using the Credibility and Expectancy Questionnaire which asks the participant to indicate how much they believe, right now, that the intervention they will receive will help manage their COP and related worry. Possible scores range from 3 to 27 for both the credibility and the expectancy subscales. Higher scores represent higher credibility and expectancy.
Conditions Studied
Interventions
- BEHAVIORAL Face-Forward-Web
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT06754917 shows while recruiting
NCT06754917 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 57-participant average among 3 other Facial Pain trials with a reported enrollment target (47% lower).
The record links to 2 conditions, with Facial Pain appearing as the primary indexed condition, and to 1 intervention - of which Face-Forward-Web is the first listed.
NCT06754917 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06754917 about?
NCT06754917 is a clinical study titled "Feasibility Testing of the "Face-Forward-Web" Program for Chronic Orofacial Pain". The goal of this study is to conduct a feasibility open pilot study (N=Up to 20) with exit interviews to assess the feasibility, acceptability, and credibility of the study protocol and Face-Forward-Web; a web-based mind-body intervention for adult patients with COP. Deliverables: \[1\] Adapt and r...
What is the current status of trial NCT06754917?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-09-15. Estimated completion is 2026-09-01.
What conditions does trial NCT06754917 study?
This clinical trial studies the following conditions: Facial Pain, Orofacial Pain.
What interventions are being tested in trial NCT06754917?
The interventions under investigation include: Face-Forward-Web (BEHAVIORAL).
Who is sponsoring clinical trial NCT06754917?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06754917 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI